Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Baxter
Harvard Business School
McKinsey
Medtronic
Moodys
Fish and Richardson
Fuji
Dow

Generated: November 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050617

« Back to Dashboard

NDA 050617 describes ERYGEL, which is a drug marketed by Mylan Pharms Inc and is included in one NDA. It is available from three suppliers. Additional details are available on the ERYGEL profile page.

The generic ingredient in ERYGEL is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 050617
Tradename:ERYGEL
Applicant:Mylan Pharms Inc
Ingredient:erythromycin
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 050617
Ingredient-typeMacrolides
Physiological EffectDecreased Sebaceous Gland Activity
Medical Subject Heading (MeSH) Categories for 050617
Suppliers and Packaging for NDA: 050617
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ERYGEL erythromycin GEL;TOPICAL 050617 NDA AUTHORIZED GENERIC Mylan Pharmaceuticals Inc. 0378-8212 0378-8212-60 1 TUBE in 1 CARTON (0378-8212-60) > 60 g in 1 TUBE
ERYGEL erythromycin GEL;TOPICAL 050617 NDA AUTHORIZED GENERIC Mylan Pharmaceuticals Inc. 0378-8212 0378-8212-93 1 TUBE in 1 CARTON (0378-8212-93) > 30 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength2%
Approval Date:Oct 21, 1987TE:ATRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Cantor Fitzgerald
Julphar
Federal Trade Commission
Accenture
Harvard Business School
Farmers Insurance
Boehringer Ingelheim
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.